Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Int J Cardiol. 2020 Jan 9;305:56–62. doi: 10.1016/j.ijcard.2020.01.012

Table 3:

Dysregulated Biomarkers in “stable” SV Fontan patients as compared to age, gender and race matched controls. Biomarkers were significantly different in various organ systems as noted above.

Case (n=44) Control (n=32) Fold Changes P value Wilcoxon ranked sum
Median (pg/mL) IQR (25th-75th percentile) Median (pg/mL) IQR (25th-75th percentile)
Inflammatory
IL-6 1.36 0.86,2.1 0.81 0.61, 1.41 1.69 0.011
TNF-α* 2.93 1.76, 2.85 0.57 0.17, 0.97 1.66 <0.001
GDF-15 908.47 675.71, 1383.68 545.77 450.885, 688.540 1.66 <0.0001
β2-microglobulin 2.41 1.551, 3.406 1.419 1.086, 1.702 1.70 0.0006
Cell mobilization
SDF1α 178.45 0.01, 556.925 0.25 0.01,253.82 713.78 0.006
Renal Function
uPAR 258.105 201.77, 308.47 203.075 120.11, 312.61 11.17 0.022
Cystatin c 438261 404053, 481752 370323 322646, 426023 1.18 <0.0001
Neurohormonal Activation
Renin 286.94 178.39, 721.42 148.5 88.36, 195.38 1.93 <0.0001
Cardiac Injury
Cardiac Troponin-I 15.375 7.99, 24.4 3.6075 0.01, 16.47 4.26 0.0004
Extracellular Matrix Turnover
Collagen-IVa 1633.31 864.65, 4138.67 497.53 362.555,805.335 3.34 <0.0001
Metabolism Regulator
Adiponectin 15.583 8.09, 39.013 8.831 5.676, 14.327 1.76 0.0037
*

TNF-α was tested in a random subset of 23 patients.